Unternehmen Institute of Biomedical Research Corp. Other OTC
Aktien
A1121A
US45781A1079
MRES
Umsatz nach Geschäftsbereich
USD in Millionen | 2014 | Gewichtung | 2015 | Gewichtung | Delta |
---|---|---|---|---|---|
Alternative Plant-based Cannabinoids and Mental hHalth Therapeutic Research
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +24,68 % |
Umsatz je Region
USD in Millionen | 2014 | Gewichtung | 2015 | Gewichtung | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +24,68 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Peter Robinson
CEO | Chief Executive Officer | - | 11.07.22 |
Willem Jonker
DFI | Director of Finance/CFO | 66 | - |
Chief Tech/Sci/R&D Officer | - | - | |
Marko Maljkovic
SAM | Sales & Marketing | - | - |
Zeljko Jacimovic
PRN | Corporate Officer/Principal | - | - |
Momir Mikov
PRN | Corporate Officer/Principal | - | - |
Veselin Delevic
PRN | Corporate Officer/Principal | - | - |
Richard Morisset
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | - | |
Peter Robinson
CEO | Chief Executive Officer | - | 11.07.22 |
Willem Jonker
DFI | Director of Finance/CFO | 66 | - |
Unternehmenskontakt
Institute of BioMedical Research Corp.
Jele Andrijasevic 2 Niksic
81004, Niksic
+
http://www.mrescorp.com